Capital Expenditures - Hofseth Biocare ASA (OSE:HBC) - Alpha Spread

Hofseth Biocare ASA
OSE:HBC

Watchlist Manager
Hofseth Biocare ASA Logo
Hofseth Biocare ASA
OSE:HBC
Watchlist
Price: 1.705 NOK -4.21% Market Closed
Market Cap: 610.1m NOK
Have any thoughts about
Hofseth Biocare ASA?
Write Note

Hofseth Biocare ASA
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hofseth Biocare ASA
Capital Expenditures Peer Comparison

Comparables:
B
BGBIO
L
LYTIX
AZT
N
NYKD
T
TRMED

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Hofseth Biocare ASA
OSE:HBC
Capital Expenditures
-kr11.2m
CAGR 3-Years
42%
CAGR 5-Years
-7%
CAGR 10-Years
3%
B
Bergenbio ASA
OSE:BGBIO
Capital Expenditures
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
L
Lytix Biopharma AS
OSE:LYTIX
Capital Expenditures
-kr49k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Arcticzymes Technologies ASA
OSE:AZT
Capital Expenditures
-kr20.6m
CAGR 3-Years
-91%
CAGR 5-Years
-50%
CAGR 10-Years
-29%
N
Nykode Therapeutics ASA
OSE:NYKD
Capital Expenditures
-$1.2m
CAGR 3-Years
-127%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Thor Medical ASA
OSE:TRMED
Capital Expenditures
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Hofseth Biocare ASA's Capital Expenditures?
Capital Expenditures
-11.2m NOK

Based on the financial report for Mar 31, 2024, Hofseth Biocare ASA's Capital Expenditures amounts to -11.2m NOK.

What is Hofseth Biocare ASA's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
3%

Over the last year, the Capital Expenditures growth was 37%. The average annual Capital Expenditures growth rates for Hofseth Biocare ASA have been 42% over the past three years , -7% over the past five years , and 3% over the past ten years .

Back to Top